BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 576837)

  • 1. 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
    Welsch CW; Adams C; Lambrecht LK; Hassett CC; Brooks CL
    Br J Cancer; 1977 Mar; 35(3):322-8. PubMed ID: 576837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
    Welsch CW
    J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.
    Heston WE; Vlahakis G; Desmukes B
    J Natl Cancer Inst; 1973 Jul; 51(1):209-24. PubMed ID: 4352748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and the development and progression of early neoplastic mammary gland lesions.
    Welsch CW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of early preneoplastic lesions of the mammary gland.
    Welsch CW
    Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and breast cancer: laboratory evidence.
    Shubik P
    IARC Sci Publ; 1985; (65):33-5. PubMed ID: 2417950
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Welsch CW; Lambrecht LK; Hassett CC
    J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1976 May; 56(5):1055-6. PubMed ID: 1036504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary carcinogenesis in female and male mice receiving contraceptives or gestagens.
    Rudali G; Coezy E; Chemama R
    J Natl Cancer Inst; 1972 Sep; 49(3):813-9. PubMed ID: 4119120
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of prenatal or neonatal administration of 2-bromo-alpha-ergocryptine on pituitary prolactin secretion and normal and neoplastic mammary growth in adult mice.
    Nagasawa H; Yanai R
    J Endocrinol Invest; 1978 Jul; 1(3):273-6. PubMed ID: 583157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary nodules in beagle dogs administered investigational oral contraceptive steroids.
    Giles RC; Kwapien RP; Geil RG; Casey HW
    J Natl Cancer Inst; 1978 Jun; 60(6):1351-64. PubMed ID: 650701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids.
    Kwapien RP; Giles RC; Geil RG; Casey HW
    J Natl Cancer Inst; 1980 Jul; 65(1):137-44. PubMed ID: 6930510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
    Welsch CW; Goodrich-Smith M; Brown CK; Wilson M
    Int J Cancer; 1979 Jul; 24(1):92-6. PubMed ID: 478693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of mutagenic activity in Salmonella by contraceptive steroids.
    Rao TK; Allen BE; Cox JT; Epler JL
    Toxicol Appl Pharmacol; 1983 Jun; 69(1):48-54. PubMed ID: 6344332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
    Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
    Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
    Nagasawa H; Morii S
    Cancer Res; 1981 May; 41(5):1935-7. PubMed ID: 7214361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral contraceptives on the mammary glands of Rhesus monkeys: a preliminary report.
    Drill VA; Martin DP; Hart ER; McConnell RG
    J Natl Cancer Inst; 1974 May; 52(5):1655-7. PubMed ID: 4208715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of carcinogen-induced breast cancer in rats by an anti-fertility drug.
    Weisburger JH; Weisburger EK; Griswold DP; Casey AE
    Life Sci; 1968 Mar; 7(5):259-66. PubMed ID: 5641718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
    Gräf KJ; Horowski R; Etreby MF
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.